tiprankstipranks
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Hong Kong Market
2126
JW (Cayman) Therapeutics Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:2126 full AI Analyst Report?

JW (Cayman) Therapeutics Co. Ltd. (2126) Cash flow

0 Followers

JW (Cayman) Therapeutics Co. Ltd. Cash Flow

HK:2126's free cash flow for Q4 2025 was ¥-23.32M. For the 2025 fiscal year, HK:2126's free cash flow was decreased by ¥270.40M and operating cash flow was ¥-21.96M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
¥ -76.85M¥ -333.44M¥ -398.42M¥ -536.72M¥ -561.20M
Investing Cash Flow
¥ -1.49M¥ -15.43M¥ 9.90M¥ -124.08M¥ -137.13M
Financing Cash Flow
¥ -169.81M¥ 90.49M¥ 275.00K¥ 112.35M¥ -30.62M
End Cash Position
¥ 503.07M¥ 757.38M¥ 1.01B¥ 1.38B¥ 1.83B
Free Cash Flow
¥ -78.46M¥ -348.87M¥ -413.00M¥ -613.60M¥ -634.28M
Currency in CNY

JW (Cayman) Therapeutics Co. Ltd. Cash Flow